Rebecca A. Betensky
- The p -Value Requires Context, Not a Threshold
2019/03/20 by Rebecca A. Betensky · 30 citations
Decision Sciences · Mathematics · Economics, Econometrics and Finance · #Meta-analysis and systematic reviews #Statistical Methods in Clinical Trials #Health Systems, Economic Evaluations, Quality of Life
- Activation of STAT3, MAPK, and AKT in Malignant Astrocytic Gliomas
2006/12/01 by Masahiro Mizoguchi, Rebecca A. Betensky, Tracy T. Batchelor +3 · 26 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Cytokine Signaling Pathways and Interactions #Cancer Mechanisms and Therapy #Melanoma and MAPK Pathways
- Phenoconversion in pure autonomic failure: a multicentre prospective longitudinal cohort study
2024/02/15 by Patricio Millar Vernetti, Lucy Norcliffe-Kaufmann, Lucy Norcliffe‐Kaufmann +25 · 15 citations
Medicine · #Parkinson's Disease Mechanisms and Treatments #Botulinum Toxin and Related Neurological Disorders #Migraine and Headache Studies
- Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring
2015/12/28 by Jacqueline E. Maye, Jacqueline Maye, Rebecca A. Betensky +12 · 2 citations
Medicine · Social Sciences · #Dementia and Cognitive Impairment Research #Alzheimer's disease research and treatments #Intergenerational Family Dynamics and Caregiving
- The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals
2019/01/21 by Reisa A. Sperling, Elizabeth C. Mormino, Aaron P. Schultz +19 · 2 citations
- Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
2006/10/06 by Mónica Garcı́a-Alloza, Monica Garcia-Alloza, Elissa M. Robbins +9 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Alzheimer's disease research and treatments #Cholinesterase and Neurodegenerative Diseases #Prion Diseases and Protein Misfolding